Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Professional Medical Expertise CoSAU:9574 42 EBITDA Margin % is 9.50% as of Dec. 2025, which is 34% below its 10-year median of 14.50. GuruFocus rates SAU:9574 with a GF Score™ of 42/100 and a GF Value™ of ﷼148.48 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 816 Medical Devices & Instruments companies, Professional Medical Expertise Co ranks better than 60.91% on this metric.
Professional Medical Expertise Co (SAU:9574) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Professional Medical Expertise Co EBITDA Margin % Related Terms
Professional Medical Expertise Co EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Professional Medical Expertise Co EBITDA Margin % Chart
Professional Medical Expertise Co Annual Data
Trend
Dec22
Dec23
Dec24
Dec25
EBITDA Margin %
16.29
15.83
11.87
13.17
Professional Medical Expertise Co Semi-Annual Data
SAU:9574 vs ABT, SYK, MDT: EBITDA Margin % Comparison
For the Medical Devices subindustry, Professional Medical Expertise Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Professional Medical Expertise Co EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Professional Medical Expertise Co's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Professional Medical Expertise Co's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Professional Medical Expertise Co (SAU:9574) has a EBITDA Margin % of 9.50% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Professional Medical Expertise Co and its competitors. This is 34% below median its historical median of 14.50. Over the past decade, Professional Medical Expertise Co's EBITDA Margin % has ranged from 11.87 to 16.29. According to the industry distribution chart, Professional Medical Expertise Co ranks #319 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 39.1%.
Is Professional Medical Expertise Co's EBITDA Margin % too high?
Professional Medical Expertise Co's current EBITDA Margin % of 9.50% is 34% below median its 10-year median of 14.50. Over the past 10 years, this metric has ranged from a low of 11.87 to a high of 16.29. The Medical Devices & Instruments industry median EBITDA Margin % is 7.52. Professional Medical Expertise Co's value of 9.50% is 26.3% above this industry median. Based on the distribution chart, Professional Medical Expertise Co ranks #319 out of 816 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Professional Medical Expertise Co has a GF Score™ of 42/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Professional Medical Expertise Co's EBITDA Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Professional Medical Expertise Co ranks #319 out of 816 companies for EBITDA Margin %. This puts Professional Medical Expertise Co in the upper half of its industry. The industry median EBITDA Margin % is 7.52. Professional Medical Expertise Co's value of 9.50% is 26.3% above this benchmark. Historically, Professional Medical Expertise Co's own EBITDA Margin % has ranged from 11.87 to 16.29 over the past decade. While the company's 10-year median is 14.50 vs. the industry median of 7.52, Professional Medical Expertise Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.52, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Professional Medical Expertise Co's current EBITDA Margin % of 9.50% is 26.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Professional Medical Expertise Co and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Professional Medical Expertise Co's current EBITDA Margin % is 9.50%, which is 34% below median its own 10-year median of 14.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Professional Medical Expertise Co stock overvalued right now?
Based on GuruFocus' analysis, Professional Medical Expertise Co (SAU:9574) is currently considered Significantly Undervalued. The stock's GF Value™ is ﷼148.48, compared to a current price of ﷼83.00 — trading 44.1% below its estimated fair value. The current EBITDA Margin % is 9.50%, which is 34% below median its 10-year median of 14.50 and 26.3% above the Medical Devices & Instruments industry median of 7.52. Professional Medical Expertise Co's overall GF Score™ is 42/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Professional Medical Expertise Co (SAU:9574), the current EBITDA Margin % is 9.50% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Professional Medical Expertise Co (SAU:9574) Overvalued in 2026?
Based on GuruFocus' analysis, Professional Medical Expertise Co stock appears to be undervalued.
The current stock price of ﷼83.00 is trading 44.1% below its estimated GF Value™ of ﷼148.48.
GuruFocus considers Professional Medical Expertise Co to be Significantly Undervalued.
Key valuation signals for SAU:9574:
EBITDA Margin %: 9.50% (34% below median its 10-year median of 14.50)
GF Value™: ﷼148.48 vs. price of ﷼83.00 (44.1% below fair value)
Industry Position: 26.3% above the Medical Devices & Instruments median (#319 of 816)
No single metric tells the full story. See the SAU:9574 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Professional Medical Expertise Co is engaged in the distribution of medical devices and related products, including the import, export, and sale of medical implants, devices, and consumables to hospitals and medical centers. Its activities include acting as sales agents for pharmaceuticals, retail sale of medical equipment and supplies, warehousing and storage of medical and pharmaceutical products, and legal representation of medical device manufacturers.
42GF Score
Get the complete analysis for SAU:9574
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAU:9574 has been successfully added to your 
